The RLR/NLR Expression and Pro-Inflammatory Activity of Tissue Mast Cells Are Regulated by Cathelicidin LL-37 and Defensin hBD-2

Scientific Reports - United Kingdom
doi 10.1038/s41598-018-30289-w
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Upregulation of Human Β-Defensin-3 and Cathelicidin LL-37 in Kaposi’s Sarcoma

F1000Research
GeneticsMolecular BiologyPharmacologyBiochemistryMicrobiology ImmunologyMedicineToxicologyPharmaceutics
2012English

Modulation of Exogenous Antibiotic Activity by Host Cathelicidin LL-37

APMIS : acta pathologica, microbiologica, et immunologica Scandinavica
ImmunologyAllergyMicrobiologyMedicineForensic MedicinePathology
2010English

The Pro-Inflammatory Peptide LL-37 Promotes Ovarian Tumor Progression Through Recruitment of Multipotent Mesenchymal Stromal Cells

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2009English

Transformation of Human Cathelicidin LL-37 Into Selective, Stable, and Potent Antimicrobial Compounds

ACS Chemical Biology
BiochemistryMedicineMolecular Medicine
2014English

Human Cathelicidin, LL-37, Inhibits Respiratory Syncytial Virus Infection in Polarized Airway Epithelial Cells

BMC Research Notes
BiochemistryMedicineGeneticsMolecular Biology
2016English

Activity of Epithelial Defensin HBD-3 Against a Periodontal Pathogen

English

Expression of Cyclooxygenase-2 and Pro-Inflammatory Cytokines Induced by 2,2′,4,4′,5,5′-Hexachlorobiphenyl (PCB 153) in Human Mast Cells Requires NF-κB Activation

Biological and Pharmaceutical Bulletin
MedicinePharmacologyPharmaceutical Science
2002English

Serum Levels of LL-37 and Inflammatory Cytokines in Plaque and Guttate Psoriasis

Mediators of Inflammation
ImmunologyCell Biology
2014English

The Effect of Calcipotriol on the Expression of HumanβDefensin-2 and LL-37 in Cultured Human Keratinocytes

Clinical and Developmental Immunology
2009English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy